The study here proposed showed, for the first time, that mTOR signaling, known to play important roles in both innate and adaptive immune responses [20], acts not only directly on immune cells in IBD, as previously described [23], but also indirectly through the intestinal lymphatic barrier. This evidence concerns the gene MTOR and inflammatory bowel disease.